Ambeed.cn

首页 / / / ACC / TOFA

TOFA {[allProObj[0].p_purity_real_show]}

货号:A126489

TOFA是一种强效、可逆且竞争性的乙酰辅酶A羧化酶(ACC)抑制剂,可抑制脂肪酸合成。

TOFA 化学结构 CAS号:54857-86-2
TOFA 化学结构
CAS号:54857-86-2
TOFA 3D分子结构
CAS号:54857-86-2
TOFA 化学结构 CAS号:54857-86-2
TOFA 3D分子结构 CAS号:54857-86-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

TOFA 纯度/质量文件 产品仅供科研

货号:A126489 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

TOFA 生物活性

描述 Acetyl-CoA carboxylase-alpha (ACCA) is a rate-limiting enzyme in long chain fatty acid synthesis, playing a critical role in cellular energy storage and lipid synthesis. TOFA (5-tetradecyloxy-2-furoic acid), an allosteric inhibitor of ACCA, is cytotoxic to lung cancer cells NCI-H460 and colon carcinoma cells HCT-8 and HCT-15, with IC50s at approximately 5.0, 5.0, and 4.5 μg/ml, respectively. TOFA at 1.0-20.0 μg/ml effectively blocked fatty acid synthesis and induced cell death in a dose-dependent manner[2]. TOFA was also cytotoxic to COC1 and COC1/DDP cells with IC50s of ~26.1 and 11.6 µg/ml, respectively. It inhibited the proliferation of the cancer cells examined in a time and dose dependent manner, arrested the cells in the G0/G1 cell cycle phase and induced apoptosis. In a human ovarian cancer mouse xenograft model, tumor growth rate was significantly inhibited by TOFA compared with the DMSO-treated control mice (1649 ± 356.3 vs. 5128 ± 390.4 mm3)[3].

TOFA 细胞实验

Cell Line
Concentration Treated Time Description References
Daudi cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
P493-6 cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
4188 cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
CD8+ T cells 1 µM 5 days Inhibited CD8+ T cell proliferation J Transl Med. 2023 Jul 4;21(1):434.
CD8+ T cells 1 µM Decreased IFN-γ, granzyme B, perforin levels J Transl Med. 2023 Jul 4;21(1):434.
CD8+ T cells 1 µM 24 hours Reduced CD69 membrane expression J Transl Med. 2023 Jul 4;21(1):434.
K562 cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
Ramos cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
BSC40 cells 154 µM 16 hours To evaluate the impact of TOFA on vaccinia virus yield. Results showed TOFA significantly inhibited viral yield by 95-fold, with partial rescue (8-fold) provided by exogenous palmitate. PLoS Pathog. 2014 Mar 20;10(3):e1004021.
PBMCs 0.08–2 µM 2 days TOFA reversed Th17/Treg imbalance and inhibited IL-2–induced STAT1/3 phosphorylation. JCI Insight. 2022 Dec 8;7(23):e162335.
HEK-293T cells 5 µM 23 hours Combination of TOFA with pimozide significantly enhanced antiviral effects. Nat Commun. 2016 May 12;7:11320.
PBMCs 0.08–10 µM 24 hours TOFA cytotoxicity was assessed using a CCK8 assay, and we found no substantial cytotoxicity of the drug when concentrations less than 10 μM were used. JCI Insight. 2022 Dec 8;7(23):e162335.
CCRF-CEM cells 0.3, 1, 3, 10 μg/mL 24-48 hours Inhibition of lipogenesis leads to apoptosis Cancer Metab. 2021 Aug 16;9(1):31.
Human bone marrow-derived stromal cells (hBMSCs) 200, 400, or 800 nM 3 days Under non-inflammatory conditions, Tofa treatment significantly decreased the gene expression of Runx2 and Dlx5 (p <0.05) and increased the gene expression of PPAR g2, C/EBPa, and Perilipin 1 (p <0.05). Under inflammatory conditions, Tofa limited the negative effect of TNF a on BMAd differentiation (p <0.05). Front Endocrinol (Lausanne). 2022 Jul 6;13:881699.
Human naive CD4 T cells 10 µM 4 days TOFA significantly increased IL-9 production by inhibiting ACC1 and reduced the proportion of Foxp3+ cells. Exogenous oleic acid restored IL-9 levels in TOFA-treated cells. Front Immunol. 2024 Dec 23;15:1509408.
Normal human epidermal keratinocytes (NHEKs) 1 µM 48 hours Inhibited production and secretion of CXCL9 and CXCL10 J Transl Med. 2023 Jul 4;21(1):434.
U2OS cells 10 µM 48 hours TOFA inhibited lipid accumulation, promoted early slippage, reduced cellular stress and enhanced survival of antimitotic-treated cells Cell Death Discov. 2018 Nov 27;4:109.
Rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) 2.5 µM 48 hours Investigate the effects of TOFA on gene expression in RA-FLS, showing that TOFA primarily downregulated gene expression, affecting interferon signaling pathways. Arthritis Res Ther. 2024 Oct 11;26(1):178.
U87 cells 39.98 µM (IC50) 5 days TOFA showed an IC50 value of 39.98 µM for U87 cells, indicating inhibitory effects on TMZ-sensitive cells. Acta Pharmacol Sin. 2023 Mar;44(3):670-679.
U87R cells 7.51 µM (IC50) 5 days TOFA showed an IC50 value of 7.51 µM for U87R cells, indicating inhibitory effects on TMZ-resistant cells. Acta Pharmacol Sin. 2023 Mar;44(3):670-679.
HeLa cells 25 µM 7 hours TOFA significantly reduced viral RNA synthesis and release, with no significant effect on cell viability. Nat Commun. 2016 May 12;7:11320.

TOFA 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Cecal ligation and perforation (CLP)-induced sepsis model Intragastric administration 1 mg/kg, 3 mg/kg, 10 mg/kg Every 6 hours for 7 days To evaluate the effect of TOFA on the survival rate of septic rats and its role in acute lung injury. The results showed that TOFA (10 mg/kg) significantly improved the survival rate of septic rats and reduced lung histopathological damage and inflammatory factor expression J Inflamm (Lond). 2023 Feb 3;20(1):5
New Zealand white rabbits Experimental rheumatoid arthritis (e-RA) Oral 10 mg/kg Once daily for two weeks To evaluate the effect of JAK inhibitors on muscle remodeling in an experimental RA model. TOFA significantly improved muscle mass and structural parameters, reduced the expression of muscle atrophy-related genes, and increased creatine kinase (CK) levels in muscle. Int J Mol Sci. 2023 Aug 24;24(17):13181
New Zealand white rabbits Antigen-induced arthritis model Oral gavage 10 mg/kg Once daily for 2 weeks To investigate the early effects of TOFA on intra-joint JAK/STAT-dependent signaling during flare-up reactions in arthritis. Results showed that TOFA partially improved synovitis, reduced levels of pSTAT1 and SOCS1, but had no effect on pSTAT3 or SOCS3. J Inflamm (Lond). 2019 Jan 29;16:2
C57BL/6 mice Adult Mice footpad injection model Intraperitoneal injection 25 mg/kg Pretreated for at least 3 days before infection and assessed 18 h p.i. TOFA significantly reduced CHIKV replication. Nat Commun. 2016 May 12;7:11320.
C57BL6/J mice GPx1/2-DKO Mice model Oral 30 mg/kg Once daily for 6 or 13 days To evaluate the efficacy of TOFA on very-early-onset ileocolitis in GPx1/2-DKO mice. Results showed that TOFA significantly inhibited crypt apoptosis and increased crypt density, but did not affect Mice growth. Life Sci. 2019 Dec 15;239:116884
C57BL/6 mice Vitiligo Mice model Intraperitoneal injection 5 mg/kg Once every other day for five weeks Alleviated the extent of depigmentation and reduced CD8+ T cell skin infiltration J Transl Med. 2023 Jul 4;21(1):434.
Mice NSG mice Intraperitoneal injection 5.5 μg/ml 4 days Inhibition of lipogenesis delays tumor progression Cancer Metab. 2021 Aug 16;9(1):31.
Lewis rats Fisher-to-Lewis rat model of kidney transplantation Oral (mixed with food) 50 mg/kg and 100 mg/kg From the third week post-transplantation until the end of the study (12 weeks) TOFA prolonged graft survival, preserved tubular and glomerular structures and reduced humoral damage characterized by C4d deposition. TOFA was able to reduce donor-specific antibodies. In addition, T and natural killer (NK) cell graft infiltration was reduced in TOFA-treated rats. Transplantation. 2018 Jul;102(7):1075-1084

TOFA 参考文献

[2]Wang C, et al. Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis. Biochem Biophys Res Commun. 2009 Jul 31;385(3):302-6

[3]Li S, et al. TOFA suppresses ovarian cancer cell growth in vitro and in vivo. Mol Med Rep. 2013 Aug;8(2):373-8

TOFA 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.08mL

0.62mL

0.31mL

15.41mL

3.08mL

1.54mL

30.82mL

6.16mL

3.08mL

TOFA 技术信息

CAS号54857-86-2
分子式C19H32O4
分子量 324.46
SMILES Code O=C(C1=CC=C(OCCCCCCCCCCCCCC)O1)O
MDL No. MFCD01726059
别名
运输蓝冰
InChI Key CZRCFAOMWRAFIC-UHFFFAOYSA-N
Pubchem ID 115175
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 10 mg/mL(30.82 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。